Table 2.

Multivariate analyses of factors associated with CRE colonization on admission to hospital.

Variables	Univariate Analysis OR (95% CI; p Value)	Multivariate Analysis OR (95% CI; p Value)
Median Karnofsky score (range)	0.97 (0.96–0.99; p < 0.001)
Neurological diseases	1.99 (1.22–3.24; p = 0.006)
Previous hospitalization within 3 months	3.52 (2.10–5.91; p < 0.001)	1.93 (1.06–3.49; p = 0.03)
Use of beta-lactams/beta-lactamase inhibitors within 3 months	3.37 (2.08–5.47; p < 0.001)	2.10 (1.20–3.66; p = 0.009)
Use of carbapenems within 3 months	4.609 (2.49–8.53; p < 0.001)	2.63 (1.29–5.35; p = 0.008)
Use of fluoroquinolones within 3 months	2.01 (1.08–3.75; p = 0.03)
Use of vancomycin within 3 months	6.76 (2.77–16.49; p < 0.001)
Use of fosfomycin within 3 months	17.53 (3.47–88.45; p = 0.001)
Previous CRE colonization	17.12 (5.31–55.24; p < 0.001)	6.95 (1.99–24.26; p = 0.002)
Previous use of nasogastric tube	2.45 (1.50–4.00; p < 0.001)
Previous use of endotracheal tube/tracheostomy tube	3.15 (1.71–5.79; p < 0.001)	2.49 (1.26–4.90; p = 0.008)
Previous use of central venous catheterization	3.73 (1.63–8.55; p = 0.002)

Abbreviation: CRE, carbapenem-resistant Enterobacterales.